These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 367159)
41. Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Klastersky J; Cappel R; Daneau D Cancer; 1973 Feb; 31(2):331-6. PubMed ID: 4569296 [No Abstract] [Full Text] [Related]
42. Timentin versus moxalactam in the treatment of skin and soft tissue infections. Tan JS; File TM; Salstrom SJ Am J Med; 1985 Nov; 79(5B):130-3. PubMed ID: 4073079 [No Abstract] [Full Text] [Related]
43. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections. Cox CE J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340 [TBL] [Abstract][Full Text] [Related]
44. Successful antimicrobial therapy of hepatic, intra-abdominal and intrapelvic abscesses. Ralph ED Can Med Assoc J; 1984 Sep; 131(6):605-7. PubMed ID: 6383589 [TBL] [Abstract][Full Text] [Related]
45. Carbenicillin indanyl sodium, an orally active derivative of carbenicillin. English AR; Retsema JA; Ray VA; Lynch JE Antimicrob Agents Chemother; 1972 Mar; 1(3):185-91. PubMed ID: 4558137 [TBL] [Abstract][Full Text] [Related]
49. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli. Parry MF; Neu HC Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895 [TBL] [Abstract][Full Text] [Related]
50. Mezlocillin in serious surgical infections caused by carbenicillin-resistant bacteria. Lewandowski A; Orlowski T; Weuta H Infection; 1982; 10 Suppl 3():S125-7. PubMed ID: 6218098 [TBL] [Abstract][Full Text] [Related]
51. Piperacillin v Carbenicillin in the therapy for serious infections. Marier RL; Sanders CV; Faro S; Janney A; Williams WW; Derks F; Aldridge KE Arch Intern Med; 1982 Oct; 142(11):2000-5. PubMed ID: 6215008 [TBL] [Abstract][Full Text] [Related]
52. [Mezlocillin in the treatment of septicemia and bronchopneumonia caused by Gram-negative bacilli]. Klastersky J; Sculier JM; Hanson B; Coppens L Nouv Presse Med; 1982 Feb; 11(5 Pt 2):383-5. PubMed ID: 6460981 [No Abstract] [Full Text] [Related]
53. Animal models for anaerobic infections. Thadepalli H Indian J Pathol Microbiol; 1985 Jan; 28(1):17-23. PubMed ID: 3914457 [No Abstract] [Full Text] [Related]
54. Evaluation of gentamicin with carbenicillin in infections due to gram-negative bacilli. Klastersky J; Cappel R; Debusscher L Curr Ther Res Clin Exp; 1971 Mar; 13(3):174-81. PubMed ID: 4998289 [No Abstract] [Full Text] [Related]
55. Activity of penicillin or ticarcillin in combination with clavulanic acid in the treatment of experimental intra-abdominal abscess. Bansal MB; Prabahala R; Thadepalli H J Antimicrob Chemother; 1986 Feb; 17(2):221-6. PubMed ID: 3700288 [TBL] [Abstract][Full Text] [Related]
56. Ticarcillin. Med Lett Drugs Ther; 1977 Feb; 19(4):17-8. PubMed ID: 402545 [No Abstract] [Full Text] [Related]
57. Ticarcillin/clavulanate in the treatment of severe peritonitis. Inthorn D; Mühlbayer D; Hartl WH J Antimicrob Chemother; 1989 Nov; 24 Suppl B():141-6. PubMed ID: 2691475 [TBL] [Abstract][Full Text] [Related]
58. Ticarcillin-clavulanate therapy for infections with ticarcillin-resistant microorganisms. Gelfand MS; Lawson RD; Baucom W South Med J; 1989 Apr; 82(4):433-7. PubMed ID: 2705069 [TBL] [Abstract][Full Text] [Related]